{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:49:25Z","timestamp":1781012965594,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neuropharm.2015.05.002","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:52:33Z","timestamp":1431478353000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Neuropeptide S reduces mouse aggressiveness in the resident\/intruder test through selective activation of the neuropeptide S receptor"],"prefix":"10.1016","volume":"97","author":[{"given":"Chiara","family":"Ruzza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Asth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Trapella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.05.002_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yhbeh.2011.10.007","article-title":"The regulation of social recognition, social communication and aggression: vasopressin in the social behavior neural network","volume":"61","author":"Albers","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bdi.12168","article-title":"Prospective longitudinal course of aggression among adults with bipolar disorder","volume":"16","author":"Ballester","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnbeh.2014.00185","article-title":"Anti-aggressive effects of neuropeptide S independent of anxiolysis in male rats","volume":"8","author":"Beiderbeck","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yhbeh.2011.11.002","article-title":"Both oxytocin and vasopressin are mediators of maternal care and aggression in rodents: from central release to sites of action","volume":"61","author":"Bosch","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-013-3124-7","article-title":"Antiaggressive activity of central oxytocin in male rats","volume":"229","author":"Calcagnoli","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib6","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/cne.22606","article-title":"Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry","volume":"519","author":"Clark","year":"2011","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/JCP.0b013e31823f8770","article-title":"The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology","volume":"32","author":"Comai","year":"2012","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/JCP.0b013e31824929d6","article-title":"The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium","volume":"32","author":"Comai","year":"2012","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib9","first-page":"10","article-title":"Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine","volume":"1","author":"Flaisher-Grinberg","year":"2010","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib10","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1021\/jm900604g","article-title":"Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists","volume":"52","author":"Guerrini","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/jm8012294","article-title":"Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists","volume":"52","author":"Guerrini","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/med.20180","article-title":"Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor","volume":"30","author":"Guerrini","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuron.2008.07.002","article-title":"Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala","volume":"59","author":"Jungling","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in\u00a0vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0160-5402(86)90038-0","article-title":"Intracerebroventricular injections in mice. Some methodological refinements","volume":"16","author":"Laursen","year":"1986","journal-title":"J.\u00a0Pharmacol. Methods"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00213-008-1080-4","article-title":"Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders","volume":"197","author":"Leonard","year":"2008","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2011.08.016","article-title":"Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects","volume":"62","author":"Lukas","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib18","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1371\/journal.pone.0002695","article-title":"Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus","volume":"3","author":"Meis","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib19","doi-asserted-by":"crossref","first-page":"e18020","DOI":"10.1371\/journal.pone.0018020","article-title":"Neuropeptide S-mediated facilitation of synaptic transmission enforces subthreshold theta oscillations within the lateral amygdala","volume":"6","author":"Meis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1124\/jpet.107.135103","article-title":"Synthesis and pharmacological in\u00a0vitro and in\u00a0vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor","volume":"325","author":"Okamura","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bjp.2008.96","article-title":"Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice","volume":"154","author":"Rizzi","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib23","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.neuropharm.2011.12.036","article-title":"Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor","volume":"62","author":"Ruzza","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.peptides.2012.01.024","article-title":"[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in\u00a0vitro and in\u00a0vivo studies","volume":"34","author":"Ruzza","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.peptides.2010.02.012","article-title":"Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68","volume":"31","author":"Ruzza","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.05.002_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2010.06947.x","article-title":"Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex","volume":"115","author":"Si","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnbeh.2014.00121","article-title":"Neuropeptide S and BDNF gene expression in the amygdala are influenced by social decision-making under stress","volume":"8","author":"Smith","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib28","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1523\/JNEUROSCI.20-24-09320.2000","article-title":"Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats","volume":"20","author":"van Erp","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0079-6123(08)00422-6","article-title":"Central vasopressin and oxytocin release: regulation of complex social behaviours","volume":"170","author":"Veenema","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib30","first-page":"24","article-title":"Violence in schizophrenia and bipolar disorder","volume":"25","author":"Volavka","year":"2013","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0022-3956(88)90073-8","article-title":"An approach to the neurology of aggression","volume":"22","author":"Weiger","year":"1988","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cne.21159","article-title":"Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain","volume":"500","author":"Xu","year":"2007","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.002_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuron.2004.08.005","article-title":"Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects","volume":"43","author":"Xu","year":"2004","journal-title":"Neuron"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:53:27Z","timestamp":1706018007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":33,"alternative-id":["S0028390815001677"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide S reduces mouse aggressiveness in the resident\/intruder test through selective activation of the neuropeptide S receptor","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}